Jörg Nink

Title: Jörg Nink: Innovator in Pharmaceutical Technologies

Introduction

Jörg Nink is a notable inventor based in Holzkirchen, Germany. He has made significant contributions to the field of pharmaceuticals, particularly in the development of innovative dosage forms. With a total of two patents to his name, Nink's work focuses on enhancing the effectiveness and delivery of pharmaceutical compounds.

Latest Patents

Nink's latest patents include a method and device for determining the disintegration time of film-shaped pharmaceutical dosage forms. This invention relates to a method for assessing how quickly these dosage forms break down, which is crucial for ensuring their efficacy. Another significant patent involves prodrugs of (1S,9S)-9-[[(1S)-1-carboxy-3-phenylpropyl]amino]octahydro-10-oxo-6H-pyridazino[1,2-a][1,2]diazepine-1-carboxylic acid. This invention focuses on diester prodrugs of cilazaprilate, which are designed to be administered topically through transdermal therapeutic systems, providing a new approach to treating hypertension and congestive heart failure.

Career Highlights

Jörg Nink is currently associated with Hexal AG, a prominent company in the pharmaceutical industry. His work at Hexal AG has allowed him to explore innovative solutions in drug formulation and delivery systems. Nink's expertise in pharmaceutical technologies has positioned him as a valuable asset in the field.

Collaborations

Throughout his career, Nink has collaborated with several talented individuals, including Josef Pichler and Katharina Obermüller. These collaborations have contributed to the advancement of his research and the successful development of his patents.

Conclusion

Jörg Nink's contributions to pharmaceutical innovations demonstrate his commitment to improving drug delivery systems. His patents reflect a deep understanding of the complexities involved in pharmaceutical formulations. Nink's work continues to influence the industry and pave the way for future advancements in medication delivery.